The expression of alpha(v) and beta3 integrin subunits in the normal human Fallopian tube epithelium suggests the occurrence of a tubal implantation window.
The co-expression of alpha1beta1, alpha4beta1 and alphavbeta3 integrins in the human endometrium coincides with the implantation window. The alphavbeta3 integrin is expressed in the apical surface of the luminal epithelium and may serve to anchor trophoblast cells in the adhesion phase of implantation. Using immunohistochemistry, we compared the expression of alphav, alpha1, alpha4 and beta3 integrin subunits in samples of normal human Fallopian tube and endometrium obtained from five women in the non-receptive period (luteal phase days 2-4) and from another five women in the receptive period (luteal phase days 6-8). The staining was quantified visually on a scale of 0 to ++, according to the intensity and density of stained cells. The alphav subunit is expressed in the Fallopian tube epithelium during both periods in a pericellular distribution. The beta3 subunit is also expressed in the same location, but it is up-regulated during the period of endometrial receptivity. The other subunits are expressed in localizations which are not relevant to trophoblast adhesion and exhibit little or no difference in the level of expression between the non-receptive and receptive periods. Based on these results we postulate that the expression of the beta3 subunit in the human tubal epithelium is under the same systemic controlling signals as in the endometrium and that the normal tubal epithelium may have an implantation window, at about the same time as the endometrium, that affords the opportunity for trophoblast attachment should a 5-7 day embryo be unduly retained in the tube.
Sülz
L
L
Unidad de Reproducción y Desarrollo, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago.
Valenzuela
J P
JP
Salvatierra
A M
AM
Ortiz
M E
ME
Croxatto
H B
HB
D015703:Antigens, CD / Q000378:metabolism*; D002448:Cell Adhesion / Q000276:immunology / Q000502:physiology; D010064:Embryo Implantation / Q000276:immunology / Q000502:physiology*; D004717:Endometrium / Q000033:anatomy & histology / Q000276:immunology / Q000378:metabolism; D004848:Epithelium / Q000033:anatomy & histology / Q000276:immunology / Q000378:metabolism; D005187:Fallopian Tubes / Q000033:anatomy & histology / Q000276:immunology / Q000378:metabolism*; D005260:Female; D006801:Humans; D039564:Integrin alphaV; D039661:Integrin beta3; D016023:Integrins / Q000378:metabolism*; D008183:Luteal Phase / Q000276:immunology / Q000378:metabolism; D010980:Platelet Membrane Glycoproteins / Q000378:metabolism*; D011247:Pregnancy; D011274:Pregnancy, Tubal / Q000209:etiology / Q000276:immunology / Q000378:metabolism; D014327:Trophoblasts / Q000276:immunology / Q000502:physiology
D015703:Antigens, CD; D039564:Integrin alphaV; D039661:Integrin beta3; D016023:Integrins; D010980:Platelet Membrane Glycoproteins